Methotrexate Treatment in Children with Febrile Ulceronecrotic Mucha-Habermann Disease: Case Report and Literature Review

Febrile Ulceronecrotic Mucha-Habermann disease is a rare and potentially fatal variant of pityriasis lichenoides et varioliformis acuta and is characterized by high fever, constitutional symptoms, and acute oncet of ulceronecrotic lesions. We present an 11-year-old male with Febrile Ulceronecrotic Mucha-Habermann disease who was cured with methotrexate and review the use of methotrexate for this disorder in the pediatric age group with the relevant literature.

[1]  Andrew J. White,et al.  Febrile Ulceronecrotic Mucha‐Habermann Disease with Central Nervous System Vasculitis , 2013, Pediatric dermatology.

[2]  C. Lok,et al.  Febrile Ulceronecrotic Mucha-Habermann Disease: Treatment with Infliximab and Intravenous Immunoglobulins and Review of the Literature , 2013, Dermatology.

[3]  D. Purvis,et al.  Febrile ulceronecrotic Mucha‐Habermann disease: A case with systemic symptoms managed with subcutaneous methotrexate , 2012, The Australasian journal of dermatology.

[4]  J. Jorizzo,et al.  Febrile Ulceronecrotic Mucha‐Habermann Disease (Pityriasis Lichenoides et Varioliformis Acuta Fulminans) Presenting as Stevens‐Johnson Syndrome , 2012, Pediatric dermatology.

[5]  J. Treat,et al.  Febrile Ulceronecrotic Mucha‐Habermann Disease in a 34‐Month‐Old Boy: A Case Report and Review of the Literature , 2012, Pediatric dermatology.

[6]  Y. Liu,et al.  Febrile Ulceronecrotic Mucha‐Habermann’s Disease with Pulmonary Involvement , 2010, Pediatric dermatology.

[7]  W. Lambert,et al.  Pityriasis lichenoides et varioliformis acuta: a disease spectrum , 2010, International journal of dermatology.

[8]  R. Chalmers,et al.  Febrile ulceronecrotic Mucha–Habermann disease: a rare dermatological emergency , 2009, Clinical and experimental dermatology.

[9]  V. Athyros,et al.  Intravenous Immunoglobulins: A Valuable Asset in the Treatment of a Case of Septic Febrile Ulceronecrotic Mucha-Habermann Disease , 2007, Dermatology.

[10]  J. Bohnsack,et al.  Septic, CD‐30 Positive Febrile Ulceronecrotic Pityriasis Lichenoides et Varioliformis Acuta , 2005, Pediatric dermatology.

[11]  P. Hoeger,et al.  Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha–Habermann disease is associated with elevated serum tumour necrosis factor‐α , 2005, The British journal of dermatology.

[12]  B. Ludviksson,et al.  The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. , 2005, Clinical immunology.

[13]  Y. Tokura,et al.  Febrile ulceronecrotic Mucha-Habermann's disease managed with methylprednisolone semipulse and subsequent methotrexate therapies. , 2003, Journal of the American Academy of Dermatology.

[14]  M. Fernández-Figueras,et al.  CLINICAL AND LABORATORY INVESTIGATIONS: Pityriasis Lichenoides in Children: Clinicopathologic Review of 22 Patients , 1998, Pediatric dermatology.

[15]  H. Kerl,et al.  Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta. , 1994, Journal of the American Academy of Dermatology.

[16]  F. Vanaclocha,et al.  Febrile ulceronecrotic Mucha-Habermann disease. , 1993, Journal of the American Academy of Dermatology.

[17]  B. Duperrat,et al.  [Hyperthermic ulcero-necrotic parapsoriasis. Subacute form of parapsoriasis guttata]. , 1966, Annales de dermatologie et de syphiligraphie.